On September 7, 2022, the State Council executive meeting decided to implement phased incentive policies for new loans for equipment purchase and renovation in some fields, and the application for interest discounts will be until December 31 this year. The meeting on September 13 decided that the special re-loan amount will exceed 200 billion yuan, and the central government will provide an interest discount of 2.5% to the loan subject for a period of two years, targeting nine major fields including universities, hospitals, and small, medium and micro enterprises. The National Health and Medical Commission further issued the “Notice on Issuing Relevant Recommendations and Reference Materials for the Use of Periodic Financial Discount Loans to Purchase Equipment” to guide medical institutions to use periodic fiscal discount loans to configure and update equipment.
The policy will be open to all public and non-public medical institutions, and the loan amount for each hospital will be no less than 20 million yuan. The use of loan funds in the medical field will include the purchase of various types of medical equipment such as diagnosis and treatment, clinical testing, critical care, rehabilitation, and scientific research transformation.
As the country ushered in a new round of medical equipment procurement, it brought new opportunities to the medical device industry and effectively enhanced the enthusiasm of domestic enterprises for the research and development of innovative medical devices. In this regard, industry insiders pointed out that the state can greatly promote and stimulate the enthusiasm of the domestic medical equipment procurement market through relevant policy adjustments, and the demand for equipment upgrades in some medical institutions will greatly increase. In the past, primary medical equipment often had shortcomings in meeting diagnosis and treatment needs, and many medical equipment have outdated functions. This policy may make this part of the market the first to improve.
As the leader in minimally invasive medical brands in China, Wuhan Half the Sky actively responds to the new needs of national policies, launches overall medical solutions, comprehensively assists the upgrading and transformation of national medical equipment, and achieves overall hospital technology improvement!
Wuhan Half the Sky Medical Technology Development Co., Ltd. is a national high-tech enterprise integrating R&D, production and sales of medical equipment. It is the first drafter of industry standards for gynecological radiofrequency therapy devices in China. The company has gathered expert resources with many well-known medical professors as the core, and is backed by well-known universities and other scientific research institutes. It has established an industry-university-research cooperation mechanism, integrating advanced electronics, computers, remote consultation, medical biomaterials, imaging and other high-tech technologies to create minimally invasive treatment products, independently developed and produced. The company has developed new medical products such as the Ureka Ultrasound System, the Tizuka Ultrasound System, the Virgina Pelvic Floor Treatment System, the Bikaxiu Breast Rotation Biopsy System, the Window Ablation Therapy System, the Autocoagulation Knife Treatment System, the Sharp Knife Treatment System, and the Dual-Energy Knife Treatment System, leading the trend of minimally invasive interventional technology. Many of its inventions have independent intellectual property rights.
